Ten Developments in the Use of Biologicals for Systemic Lupus Erythematosus

被引：1
|
作者：
Wallace, Daniel J. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA 90095 USA
来源：
CURRENT RHEUMATOLOGY REPORTS | 2013年 / 15卷 / 07期
关键词：
Biologicals; Targeted therapy; Systemic lupus erythematosus; SLE; FDA; Treatment; Cutaneous lupus; Belimumab; Epratuzumab; T cell inhibition; B-LYMPHOCYTE STIMULATOR; DOUBLE-BLIND; DISEASE-ACTIVITY; PHASE-I; MONOCLONAL-ANTIBODY; CONTROLLED-TRIAL; SAFETY; BELIMUMAB; EFFICACY; RITUXIMAB;
D O I：
10.1007/s11926-013-0337-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Belimumab has recently been approved, and several other types of biological therapy with different mechanisms of action are currently in phase II and III studies. This review puts these approaches in context, emphasizing mechanistic categories and clinical trial designs. Most of the promising approaches involve B cell depletion or modulation. Post-approval experience with belimumab is critically reviewed.
引用
收藏
页数：8
相关论文
共 50 条
  • [21] Treatment of systemic lupus erythematosus
    McKeon, Kathryn P.
    Jiang, Simon H.
    AUSTRALIAN PRESCRIBER, 2020, 43 (03) : 85 - 90
  • [22] Biologic therapies for the treatment of systemic lupus erythematosus
    Park, Sung-Hoon
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (02): : 109 - 115
  • [23] One year in review 2019: systemic lupus erythematosus
    Zucchi, D.
    Elefante, E.
    Calabresi, E.
    Signorini, V.
    Bortoluzzi, A.
    Tani, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (05) : 715 - 722
  • [24] Advances in Targeted Therapy for Systemic Lupus Erythematosus: Current Treatments and Novel Approaches
    Saegusa, Kazusa
    Tsuchida, Yumi
    Komai, Toshihiko
    Tsuchiya, Haruka
    Fujio, Keishi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [25] Treatment of systemic lupus erythematosus: New therapeutic options
    Gonzalez-Garcia, A.
    Cusacovich, I.
    Ruiz-Irastorza, G.
    REVISTA CLINICA ESPANOLA, 2023, 223 (10): : 629 - 639
  • [26] Update on the Use of Biologics in Lupus
    Relan, Manisha
    Vishwanath, Sahana
    Shen, Long
    Ambrus, Julian L., Jr.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (06) : 516 - 520
  • [27] Systemic lupus erythematosus
    Tanaka, Yoshiya
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2022, 36 (04):
  • [28] Biologic therapies in systemic lupus erythematosus
    Bernal, Christine B.
    Zamora, Leonid D.
    Navarra, Sandra V.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (02) : 146 - 153
  • [29] Epratuzumab for the treatment of systemic lupus erythematosus
    Geh, Daniel
    Gordon, Caroline
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (04) : 245 - 258
  • [30] Biologics in the treatment of systemic lupus erythematosus
    Lateef, Aisha
    Petri, Michelle
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (05) : 504 - 509
12345